Alphabet's Verily in digital research alliance with Pfizer and others
Verily, which is a subsidiary of Google’s parent company Alphabet, yesterday announced that it had partnered with Novartis, Otsuka, Pfizer, and Sanofi in efforts to develop digitally-innovative clinical research programmes.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
16 March 2018 Technology companies Alphabet, Apple and Microsoft filed applications for 313 US healthcare patents between 2013 and 2017, according to a report issued by professional services firm Ernst & Young.
17 June 2019 US biopharmaceutical company Pfizer has entered agreed to acquire Array BioPharma, a biotechnology company which develops small molecule drugs for the treatment of cancer.
16 March 2018 Technology companies Alphabet, Apple and Microsoft filed applications for 313 US healthcare patents between 2013 and 2017, according to a report issued by professional services firm Ernst & Young.
17 June 2019 US biopharmaceutical company Pfizer has entered agreed to acquire Array BioPharma, a biotechnology company which develops small molecule drugs for the treatment of cancer.
16 March 2018 Technology companies Alphabet, Apple and Microsoft filed applications for 313 US healthcare patents between 2013 and 2017, according to a report issued by professional services firm Ernst & Young.
17 June 2019 US biopharmaceutical company Pfizer has entered agreed to acquire Array BioPharma, a biotechnology company which develops small molecule drugs for the treatment of cancer.
